Decrease text size Increase text size

Clinical Trials

Trials currently recruiting at Ballarat Health Service in Oncology


  • Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers - An International, Multi-Center, Double Blind, Randomized Placebo Controlled Phase III Trial


  • A Phase III, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Copanlisib in Combination With Rituximab in Patients With Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)

JAVELIN Lung 100

  • A Phase III, Open-label, Multicenter Trial of Avelumab (MSB0010718C) Versus Platinum-based Doublet as a First-line Treatment of Recurrent or Stage IV PD-L1+ Non-small Cell Lung Cancer


  • A Randomized, Open-Label Study Comparing the Combination of YONDELIS and DOXIL/CAELYX With DOXIL/CAELYX Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (Other ID's: CR100983, ET743OVC3006, 2012-004808-34)


  • A Multicentre Randomized Phase II Trial Comparing Nab-Paclitaxel to Paclitaxel in Patients With Advanced Urothelial Cancer Progressing on or After a Platinum Containing Regimen


  • A phase III study of the impact of a physical activity program on disease - free survival in patients with high risk stage II or stage III colon cancer: a randomised controlled trial


  • Study title: A Phase III Open-Label, Multicentre Trial of Maintenance Therapy with Avelumab (MSB0010718C) Versus Continuation of First-Line Chemotherapy in Subjects with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of Stomach, or of the esophageal junction,


  • A Pivotal Pharmacokinetic Bioequivalence Study Comparing Generic to Reference Liposome-Encapsulated Doxorubicin Hydrochloride in Subjects with Epithelial Ovarian Carcinoma Who Have Failed Platinum-Based Chemotherapy